[ad_1]
L & # 39; automatic
technique, using flow cytometry imaging, allows patients with leukemia to be monitored
at any stage of their illness to assess their response to treatment and provide
an early indicator of recurrence.
A first medical invention of the world
University researchers
of Western Australia (UWA) can detect abnormal chromosomes in the interior
leukemic cells.
According to the announcement
made by UWA, their invention is a finalist for the 2018 Australian
Eureka Museum Award for its ability to detect as little as one
abnormal cell in 10,000 normal cells, which is considered a significant improvement
on existing detection methods.
This is good news for patients
leukemia as they can now be closely monitored at any stage of their illness
in order to evaluate their response to treatment. This will also provide a
early indication of recidivism.
The diagnosis of cancer will be greatly
improved, which will lead to more individualized treatments and a better patient
care.
Immuno-flowFISH is an automated technique
which uses flow cytometry developed by Professor Wendy Erber, Dr. Kathy
Fuller and Mr. Henry Hui of UWA Medical School.
Chronic lymphocytic leukemia is the most
common type of leukemia in Australia that affects 3% of people over 60 years.
The Immuno-flowFISH method was used by the team to study this type of
leukemia
Professor Wendy Erber explained that
The method adds a new dimension to how leukemia can be assessed and how treatment
decisions are made.
She added that they have now expanded
test so that it can be applied to other types of leukemia and cancers
well, pointing out that the method they invented offers an important
potential impact for patients with these diseases.
In addition, the invention promises a new era
for diagnostic accuracy, personalized treatment and overall health outcomes for
cancer patients.
Excellence in the fields of research and
innovation, leadership, scientific engagement and school science are generally
recognized at the annual awards of the Australian Museum Eureka. For the Immuno-flowFISH
UWA has been selected as finalist Eureka for innovative use
Technology
Professor Erber shared that being selected
as a finalist for the Eureka award was a great honor and the research team was
delighted to have their work recognized because of the difference that it's going to
to the patients.
The laureates include scientists and
researchers whose contributions help solve some of the biggest
challenges that humanity faces and foster the next generation of
Leaders and Research Scientists
Eureka Award Winners Announced
on August 29, 2018.
Source link
